CDKN2A and neoplasm: To confirm if the results we observed in bioinformatics analyses successfully translated into clinic, we analyzed the expression of CDKN2A protein by IHC (Figure 7(a)) and the methylation by MS-PCR with 62 GC specimens and 62 non-tumor tissues (Figure 7(b)).